Review of Section 14 of the Patent Act Amendment 1992 (Chapter 2, Statutes of Canada, 1993)
WITNESSES:
Allelix Biopharmaceuticals Inc. / Industrial Biotechnology Association of Canada:
Graham Strachan, President and Chief Executive Officer / Director.
Efamol Research:
Michael Winther, President and Chief Executive Officer.
Industrial Biotechnology Association of Canada:
Joyce Groote, President.
University of Toronto:
Dan Drucker, Physician and Researcher.